BioCentury
ARTICLE | Distillery Therapeutics

Cancer

November 6, 2018 8:48 PM UTC

Patient sample, cell culture and mouse studies suggest inhibiting PRMT2 could help treat glioblastoma multiforme (GBM). In GBM patients, high tumor levels of PRMT2 were associated with poor survival. ...